| Views | |
|---|---|
| Targeted treatment in a case series of AR+, HRAS/PIK3CA co-mutated salivary duct carcinoma | 78 |
| March 2025 | April 2025 | May 2025 | June 2025 | July 2025 | August 2025 | September 2025 | |
|---|---|---|---|---|---|---|---|
| Targeted treatment in a case series of AR+, HRAS/PIK3CA co-mutated salivary duct carcinoma | 2 | 0 | 16 | 3 | 4 | 2 | 4 |
| Views | |
|---|---|
| 2024_Rieke_etal.pdf | 47 |
